Search Results - "Gibb, Adam"

Loncastuximab tesirine in relapsed/refractory diffuse large B-cell lymphoma: drug profile and expert opinion on the prevention and management of adverse events.

Authors: Derenzini, Enrico Gibb, Adam Kwiatek, Michał et al.

Source: Leukemia & Lymphoma. Nov2025, Vol. 66 Issue 11, p1990-2002. 13p.

Results of a UK National Cancer Research Institute Phase II study of brentuximab vedotin using a response‐adapted design in the first‐line treatment of patients with classical Hodgkin lymphoma unsuitable for chemotherapy due to age, frailty or comorbidity (BREVITY)

Authors: Gibb, Adam Pirrie, Sarah J. Linton, Kim et al.

Source: British Journal of Haematology. Apr2021, Vol. 193 Issue 1, p63-71. 9p.

Bendamustine can be a bridge to allogeneic transplantation in relapsed Hodgkin lymphoma refractory to brentuximab vedotin.

Authors: Howell, Matthew Gibb, Adam Radford, John et al.

Source: British Journal of Haematology. Dec2017, Vol. 179 Issue 5, p841-843. 3p. 2 Charts.

Outcomes following front-line chemotherapy in peripheral T-cell lymphoma: 10-year experience at The Royal Marsden and The Christie Hospital.

Authors: Gleeson, Mary Peckitt, Clare Cunningham, David et al.

Source: Leukemia & Lymphoma. Jul2018, Vol. 59 Issue 7, p1586-1595. 10p.

Allogeneic transplant following brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphoma and systemic anaplastic large cell lymphoma.

Authors: Illidge, Tim Bouabdallah, Reda Chen, Robert et al.

Source: Leukemia & Lymphoma. Mar2015, Vol. 56 Issue 3, p703-710. 8p.

Results of a multicentre UK-wide retrospective study evaluating the efficacy of brentuximab vedotin in relapsed, refractory classical Hodgkin lymphoma in the transplant naive setting.

Authors: Eyre, Toby A. Phillips, Elizabeth H. Linton, Kim M. et al.

Source: British Journal of Haematology. Nov2017, Vol. 179 Issue 3, p471-479. 9p.

Bilateral adrenal masses and adrenal insufficiency: a rare case of primary adrenal lymphoma.

Authors: Eladl A Michaelidou M Gibb A et al.

Source: Endocrinology, diabetes & metabolism case reports [Endocrinol Diabetes Metab Case Rep] 2026 Feb 19; Vol. 2026 (1). Date of Electronic Publication: 2026 Feb 19 (Print Publication: 2026).

Publication Type: Case Reports; Journal Article

Journal Info: Publisher: Bioscientifica Country of Publication: England NLM ID: 101618943 Publication Model: Electronic-Print Cited Medium: Print ISSN: 2052-0573 (Print) Linking ISSN: 20520573 NLM ISO Abbreviation: Endocrinol Diabetes Metab Case Rep Subsets: PubMed not MEDLINE

Outcomes after chimeric antigen receptor T-cell therapy across large B-cell lymphoma subtypes.

Authors: Bourlon C Roddie C Menne T et al.

Source: Haematologica [Haematologica] 2024 Aug 01; Vol. 109 (8), pp. 2716-2720. Date of Electronic Publication: 2024 Aug 01.

Publication Type: Letter

Journal Info: Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Electronic Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE

Treatment outcomes in patients with large B-cell lymphoma after progression to chimeric antigen receptor T-cell therapy.

Authors: Iacoboni G Iraola-Truchuelo J O'Reilly M et al.

Source: HemaSphere [Hemasphere] 2024 May 21; Vol. 8 (5), pp. e62. Date of Electronic Publication: 2024 May 21 (Print Publication: 2024).

Publication Type: Journal Article

Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 101740619 Publication Model: eCollection Cited Medium: Internet ISSN: 2572-9241 (Electronic) Linking ISSN: 25729241 NLM ISO Abbreviation: Hemasphere Subsets: PubMed not MEDLINE

Ibrutinib as first-line therapy for mantle cell lymphoma: a multicenter, real-world UK study.

Authors: Tivey A Shotton R Eyre TA et al.

Source: Blood advances [Blood Adv] 2024 Mar 12; Vol. 8 (5), pp. 1209-1219.

Publication Type: Observational Study; Multicenter Study; Journal Article

Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

Safety of bendamustine for the treatment of indolent non-Hodgkin lymphoma: a UK real-world experience.

Authors: Shotton R Broadbent R Alchawaf A et al.

Source: Blood advances [Blood Adv] 2024 Feb 27; Vol. 8 (4), pp. 878-888.

Publication Type: Multicenter Study; Observational Study; Journal Article

Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

Treatment patterns and outcomes of unfit and elderly patients with Mantle cell lymphoma unfit for standard immunochemotherapy: A UK and Ireland analysis.

Authors: Rampotas A Wilson MR Lomas O et al.

Source: British journal of haematology [Br J Haematol] 2021 Jul; Vol. 194 (2), pp. 365-377. Date of Electronic Publication: 2021 May 07.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE

Fractures are common within 18 months following first-line R-CHOP in older patients with diffuse large B-cell lymphoma.

Authors: Booth S Plaschkes H Kirkwood AA et al.

Source: Blood advances [Blood Adv] 2020 Sep 22; Vol. 4 (18), pp. 4337-4346.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

Gamma-delta T-cell lymphoma of skin, eye and brain presenting with visual loss.

Authors: Jones N Gibb A Irion L et al.

Source: BMJ case reports [BMJ Case Rep] 2017 Jun 15; Vol. 2017. Date of Electronic Publication: 2017 Jun 15.

Publication Type: Case Reports; Journal Article

Journal Info: Publisher: BMJ Pub. Group Country of Publication: England NLM ID: 101526291 Publication Model: Electronic Cited Medium: Internet ISSN: 1757-790X (Electronic) Linking ISSN: 1757790X NLM ISO Abbreviation: BMJ Case Rep Subsets: MEDLINE

Brentuximab vedotin in refractory CD30+ lymphomas: a bridge to allogeneic transplantation in approximately one quarter of patients treated on a Named Patient Programme at a single UK center.

Authors: Gibb A Jones C Bloor A et al.

Source: Haematologica [Haematologica] 2013 Apr; Vol. 98 (4), pp. 611-4. Date of Electronic Publication: 2012 Oct 12.

Publication Type: Journal Article

Journal Info: Publisher: Ferrata Storti Foundation Country of Publication: Italy NLM ID: 0417435 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1592-8721 (Electronic) Linking ISSN: 03906078 NLM ISO Abbreviation: Haematologica Subsets: MEDLINE

Burkitt's lymphoma of an ileal pouch following restorative proctocolectomy.

Authors: Smart CJ Gibb A Radford J

Source: Inflammatory bowel diseases [Inflamm Bowel Dis] 2012 Aug; Vol. 18 (8), pp. E1596-7. Date of Electronic Publication: 2012 Jan 31.

Publication Type: Case Reports; Letter

Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 9508162 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1536-4844 (Electronic) Linking ISSN: 10780998 NLM ISO Abbreviation: Inflamm Bowel Dis Subsets: MEDLINE